Transfusion guidelines and liver transplantation: Time for consensus

Liver Transplantation

Volumn 13, Issue 12, 2007, Pages 1630-1632

  Lopez Plaza, Ileana ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT;

ALLOIMMUNITY; ANEMIA; BLEEDING; BLOOD GROUP ABO SYSTEM; BLOOD GROUP RHESUS SYSTEM; BLOOD TRANSFUSION; CLINICAL PRACTICE; CONSENSUS DEVELOPMENT; EDITORIAL; ERYTHROCYTE TRANSFUSION; FIBRINOGEN BLOOD LEVEL; GRAFT SURVIVAL; HEART TRANSPLANTATION; HEMATOCRIT; HISTOCOMPATIBILITY; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; OPERATION DURATION; PEROPERATIVE CARE; PLASMA TRANSFUSION; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK FACTOR; SURGICAL MORTALITY; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ABO BLOOD-GROUP SYSTEM; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; ERYTHROCYTE COUNT; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; KAPLAN-MEIERS ESTIMATE; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 37549035890     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21225     Document Type: Editorial

References (18)

1. Ozier Y, Pessione F, Samain E, Courtois F for the French Study Group on blood transfusion in liver transplantation. Institutional Variability in Transfusion Practice for Liver Transplantation. Anesth Analg 2003;97:671-679.
2. Xia VW, Du B, Braunfeld M, Neelakanta G, Hu KQ, Nourmand H, et al. Preoperative characteristics and intraoperative transfusion and vasopressor requirements in patients with low vs. high MELD scores. Liver Transpl 2006; 12:614-620.
3. Massicotte L, Sassine MP, Lents S, Seal RF, Roy A. Survival rate changes with transfusion of blood products during liver transplantation. Can J Anesth 2005;52:148-155.
4. Ramsey G, Sherman LA. Transfusion therapy in solid organ transplantation. Hematol Oncol Clin North Am 1994; 8:1117-1129.
5. Boyd SD, Stenard F, Lee DKK, Goodnough LT, Esquivel C, Fontaine MJ. Alloimmunization to red blood cell antigens affects clinical outcomes in liver transplant patients. Liver Transpl 2007;13:1654-1661.
6. Rosse WF, Gallagher D, Kinney TR, Castro O, Dosik H, Moohr J, et al. Transfusion and alloimmunization in sickle cell disease. The cooperative study of sickle cell disease. Blood 1990;76:1431-1437.
7. Buetens O, Shirey RS, Goble-Lee M, Houp J, Zachary A, King KE, Ness PM. Prevalence of HLA antibodies in transfused patients with and without red cell antibodies. Transfusion 2006;46:754-756.
8. Weber T, Marino IR, Kang YG, Esquivel CD, Starzl TE, Duquesnoy P.J. Intraoperative blood transfusion in highly alloimmunized patients undergoing orthotopic liver transplantation. Transplantation 1989;47:797-801.
9. Matinlauri IH, Nurminen MM, Höckerstedt KA, Isoniemi HM. Risk factors predicting survival of liver transplantation. Transplant Proc 2005;37:1155-1160.
10. Bishara A, Brautbar C, Eid A, Scherman L, Ilan Y, Safadi R. Is presensitization relevant to liver transplantation outcome? Human Immunol 2002;63:742.
11. Schroeder RA, Johnson LB, Plotkin JS, Kuo PC, Klein AS. Total blood transfusion and mortality after orthotopic liver transplantation. Anesthesiology 1999;91:329. [Correspondence]
12. Cacciarelli TV, Keeffe EB, Moore DH, Burns W, Busque S, Concepcion W, et al. Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. Arch Surg 1999;134:25-29.
13. Findlay JY, Rettke SR. Poor prediction of blood transfusion requirements in adult liver transplantations from preoperative variables. J Clin Anesth 2000;12:319-323.
14. Ramos E, Dalmau A, Sabate A, Lama C, Llado L, Figueras J, Jaurrieta E. Intraoperative red blood cell transfusion in liver transplantation: influence on patient outcome, prediction of requirements, and measures to reduce them. Liver Transplant 2003;9:1320-1327.
15. Lee DS, Gil WH, Lee HH, Lee KW, Lee SK, Kim SJ, et al. Factors affecting graft survival after living donor liver transplantation. Transplant Proc 2004;36:2255-2256.
16. Findlay JY, Rettke SR, Ereth MH, Plevak DJ, Krom RAF, Kufner RP. Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomized, double-blind study. Liver Transpl 2001;7:802-807.
17. Ramsey G, Cornell FW, Hahn LF, Incompatible blood transfusions in liver transplant patients with significant red cell alloantibodies. Transplant Proc 1989;21:3531.
18. Jabbour N, Gagandeep S, Mateo R, Sher L, Strum E, Donovan J, et al. Live donor liver transplantation without blood products: strategies developed for Jehovah's witnesses offer broad application. Arch Surg 2006; 141:913-917.